Sign in

CIK 0000034956

  • Non-accelerated filer
  • Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262593535
Phone
+1 919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
Open-market buys, last 90 days
$4,770,520
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$4,770,520. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-11 STAAB THOMAS R II Chief Financial Officer Purchase +5,675 $1.94 $11K 15,675
2026-05-11 STAAB THOMAS R II Chief Financial Officer Grant or award +10,000 10,000
2026-05-11 STAAB THOMAS R II Chief Financial Officer Grant or award · Stock Option (right to buy) +450,000 450,000

Page 1 of 1 · 3 trades